Brexpiprazole CAS 913611-97-9 Maʻemaʻe >99.0% (HPLC) API Factory Featured Image

Brexpiprazole CAS 913611-97-9 Maʻemaʻe >99.0% (HPLC) API Hale Hana

ʻO ka wehewehe pōkole:

Inoa Kemika: Brexpiprazole

CAS: 913611-97-9

Maʻemaʻe: >99.0% (HPLC)

ʻAno: Keʻokeʻo a i ʻole Keʻokeʻo Crystalline Powder

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

ʻO Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-hoʻokahi CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Na Waiwai Kemika:

Inoa Kimia	ʻO Brexpiprazole
Nā huaʻōlelo like	OPC-34712;7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
Helu CAS	913611-97-9
Helu CAT	RF-PI1982
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C25H27N3O2S
Kaumaha Molecular	433.57
ʻO ka mānoanoa	1.245±0.060 g/cm3
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a i ʻole ke keʻokeʻo Crystalline pauda
ʻIkepili	Na IR
RT	Ma lalo o chirality pono e hoʻokō
Klorida	Hāʻawi ia i ka hopena o ka chloride
Wai	3.0%~4.5%
Lae hehee	198.0~202.0 ℃
Koena ma ka Ignition	<0.20%
Nā Metala Kaumaha	≤10ppm
Na mea pili
Ka haumia o ke kanaka	<0.50%
Huina paumaele	<1.00%
EE	>99.0%
Maʻemaʻe / Kaʻina Hanana	>99.0% (HPLC, ma ke kumu maloʻo)
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	API

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

Noi:

ʻO Brexpiprazole (CAS: 913611-97-9) he moho lāʻau kūpono i ka mālama ʻana a me ka pale ʻana i nā maʻi noʻonoʻo me nā maʻi CNS.ʻO Brexpiprazole kahi lāʻau antipsychotic hou e lawelawe nei ma ke ʻano he serotonin ® dopamine activity modulator a ua hōʻike i ka pono ma ke ʻano he lāʻau hoʻohui i nā maʻi me ka maʻi depressive nui (MDD).Hōʻike ʻo Brexpiprazole i kahi ʻano lāʻau lapaʻau kūʻokoʻa, e hana ana ma ke ʻano he agonist ʻāpana o ka serotonin 5-HT1A a me ka dopamine D2 receptors a ma ke ʻano he antagonist piha o 5-HT2A a me noradrenaline α1B / 2C receptors, me ka subnanomolar binding affinity.Ua hoʻomohala ʻia ʻo Brexpiprazole e Otsuka a me Lundbeck, ua ʻae ʻia ma 2015 e ka FDA no ka mālama ʻana i ka schizophrenia a ma ke ʻano he lāʻau hoʻohui no ke kaumaha.Ua manaʻo nui ʻia ʻo Brexpiprazole he mea pani i ka lāʻau lapaʻau antipsychotic o Otsuka aripiprazole (inoa kālepa Abilify) i pau ka patent i ʻAukake 2014.